Welcome to Onco Life Centre Podcast.

A European regulatory committee has recommended a new treatment for metastatic pancreatic cancer, a once-daily oral pill for adults who have already tried one therapy. This episode explains what the trial results show, what the side effects are, and what happens next.

You'll learn:
- What the European committee recommended and who it would treat
- Why a final decision from the European Commission is still needed
- How patients on the pill lived longer than those on chemotherapy in a 500-patient trial
- How tumor shrinkage and time to worsening pain compared between the two groups
- The most common side effects, and the serious risks to know about
- Why pancreatic adenocarcinoma is often found late and is hard to treat
- Why experts say the pill is not a cure and how resistance can develop
- What patients and families can ask their oncology team right now

This is a regulatory recommendation, not a final approval, and access will vary by country. We hope this episode helps you understand the news and prepare better questions for your care team.

Blog Link: EU Panel Backs New Treatment for Advanced Pancreatic Cancer

Send us Fan Mail

Thank you for listening to The Onco Life Podcast, your trusted source for expert cancer information and patient-centered education.

Author: Dr. CHRISTINA NG VAN TZE

📍 Visit us at oncolifecentre.com
📞 Call: +60 3 2242 3260
📧 Book a consultation or ask a question — we're here to support your journey.